Gestodene clinical trials
How each study uses Gestodene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2009 (8)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 8 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 3
Bayer (11) · Hospital Geral de Fortaleza (1) · Mahidol University (1) · Ain Shams University (1)
Often tested with
Tested in the same studies.
Ethinyl Estradiol (13) · Estradiol (1) · Nomegestrol acetate (1)
Related medicines
As reviewed, each with the page that says it.
- One of Progestins source
Studies
Open first, then newest update. How each study uses Gestodene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 CyclesCompletedPhase 3BayerNCT00910637Written as Gestodene/EE Patch (BAY86-5016)
- US Ovulation Inhibition Study in Obese WomenCompletedPhase 2BayerNCT00873483Written as Ethinylestradiol/Gestodene (BAY86-5016)
- OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist ProtocolStatus unknownPhase 1/2Ain Shams UniversityNCT03881904Written as 0.075mg gestodene/0.03mg ethinylestradiol
- Comparison of Coagulation Profiles Between Zoely and Minidoz: RCTTerminatedPhase 4Mahidol UniversityNCT03531437Written as 15 µg ethinylestradiol and 60 µg gestodene
- Russia/Ukraine Suppression of Ovarian Activity StudyCompletedPhase 2BayerNCT02550977Written as Gestodene/EE Patch (BAY86-5016)
- US Cycle Control and Blood Pressure StudyCompletedPhase 3BayerNCT00920985Written as Gestodene/EE (FC Patch Low, BAY86-5016)
- EU/LA Pearl Index Study - Transdermal Contraceptive PatchCompletedPhase 3BayerNCT00914693Written as Ethinylestradiol/Gestodene (BAY86-5016)
- Inhibition of Ovulation, Patch, Ethinylestradiol and GestodeneTerminatedPhase 2BayerNCT00729404Written as Ethinylestradiol/Gestodene (BAY86-5016)
- FC Patch Low: Metabolism StudyCompletedPhase 2BayerNCT00933179Written as Gestodene/EE Patch (BAY86-5016)
- Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.CompletedPhase 2BayerNCT01204190Written as Gestodene/EE Patch (BAY86-5016)
- Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)CompletedPhase 2BayerNCT00915915Written as Ethinylestradiol/Gestodene (BAY86-5016)
- Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications SitesCompletedPhase 1BayerNCT01083264Written as Gestodene/EE Patch (BAY86-5016)
- Birth Control Patch StudyCompletedPhase 3BayerNCT00984789Written as Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
- Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of MenacmeCompletedPhase 4Hospital Geral de FortalezaNCT01174524Written as gestoden 60 mcg
Codes
What other systems call Gestodene · ClinicalTrials.gg INT003000
- MeSH (NLM) C033273GestodeneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1664P6E6MIGESTODENEConfirmed FDA, NLM, Wikidata
- RxNorm 25734Confirmed FDA, Wikidata
- Wikidata Q408289gestodeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87240GestodeneOne source FDA
- DrugBank DB06730One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C033273 | Gestodene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1664P6E6MI | GESTODENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 25734 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408289 | gestodene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87240 | Gestodene | One source FDA |
| DrugBank | DB06730 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.